Cancer Genomic (CGx) Testing
$640.00
This test assesses genetic mutations associated with hereditary cancer syndromes and can be a vaulable tools for individuals with hereditary cancer risk.
Genes: APPC, BLM, BRCA1, BRCA2, FANCC, MLH1, MSH1, MSH2, MSH6, PALB2, PMS2, PTEN, TP53
Quantity:
This test assesses genetic mutations associated with hereditary cancer syndromes and can be a vaulable tools for individuals with hereditary cancer risk.
Genes: APPC, BLM, BRCA1, BRCA2, FANCC, MLH1, MSH1, MSH2, MSH6, PALB2, PMS2, PTEN, TP53
This test assesses genetic mutations associated with hereditary cancer syndromes and can be a vaulable tools for individuals with hereditary cancer risk.
Genes: APPC, BLM, BRCA1, BRCA2, FANCC, MLH1, MSH1, MSH2, MSH6, PALB2, PMS2, PTEN, TP53